STABILISING EXCIPIENT FOR INACTIVATED WHOLE-VIRUS VACCINES

The invention relates to a vaccine composition containing: (a) inactivated whole virus; and (b) a stabilising excipient comprising (i) a buffer solution, (ii) a mixture of essential and non-essential amino acids, (iii) a disaccharide, (iv) a polyol, (v) a chelating agent, (vi) urea or a urea derivat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ALAIN FRANCON, ERIC CALVOSA, NADEGE MORENO, VIRGINIE FABRE, MICHEL CHEVALIER, SANDRINE CIGARIRNI
Format: Patent
Sprache:eng ; spa
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The invention relates to a vaccine composition containing: (a) inactivated whole virus; and (b) a stabilising excipient comprising (i) a buffer solution, (ii) a mixture of essential and non-essential amino acids, (iii) a disaccharide, (iv) a polyol, (v) a chelating agent, (vi) urea or a urea derivative, and (vii) a non-ionic surfactant. La invención se relaciona a una composición de vacuna que contiene: (a) virus entero inactivado; y (b) un excipiente estabilizante que comprende (i) una solución reguladora, (ii) una mezcla de aminoácidos esenciales y no esenciales, (iii) un disacárido, (iv) un poliol, (v) un agente quelante, (vi) urea o un derivado de urea y (vii) un surfactante no iónico.